Philip T. Cagle

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley et al. · Journal of Thoracic Oncology · 2013 · 1.3K citations · Full text

Medicine, Molecular Medicine, Oncology +17

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Archives of Pathology & Laboratory Medicine · 2018 · 931 citations · Full text

Medicine, Oncology, Pathology +17

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Journal of Thoracic Oncology · 2018 · 633 citations · Full text

Medicine, Molecular Medicine, Oncology +16

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group

Aliya N. Husain, Thomas V. Colby, Nelson G. Ordóǹez et al. · Archives of Pathology & Laboratory Medicine · 2012 · 465 citations

Medicine, Oncology, Pathology +17

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley et al. · Journal of Molecular Diagnostics · 2013 · 461 citations

Medicine, Molecular Medicine, Oncology +17